×
0 0 0 0 0 -0.000813669650122033 -0.0235964198535395 0
Analyst impact report

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) had its price target raised by analysts at Cantor Fitzgerald from $12.00 to $22.00. They now have an "overweight" rating on the stock.

Zynerba Pharmaceuticals (ZYNE)  More Company Research Source: MarketBeat
Last zynerba pharmaceuticals earnings: 8/6 06:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.zynerba.com
Impact snapshot Event time: ZYNE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ZYNE alerts
from News Quantified
Opt-in for
ZYNE alerts

from News Quantified
Opt-in for
ZYNE alerts

from News Quantified